α-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death

被引:70
作者
Cheng, Furong [2 ]
Li, Xin [2 ]
Li, Yaohua [2 ]
Wang, Chaodong [2 ]
Wang, Tao [2 ]
Liu, Guangwei [2 ]
Baskys, Andrius [3 ]
Ueda, Kenji [2 ,4 ]
Chan, Piu [2 ]
Yu, Shun [1 ,2 ]
机构
[1] China Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing 100053, Peoples R China
[2] China Capital Med Univ, Xuanwu Hosp, Key Lab Neurodegenerat Dis,Capital Med Univ, Sino Japan Joint Lab Neurodegenerat Dis,Minst Edu, Beijing 100053, Peoples R China
[3] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Kern Psychiat Residency Program, Kern Med Ctr & Kern Cty Mental Hlth, Bakersfield, CA USA
[4] Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan
基金
中国国家自然科学基金;
关键词
alpha-synuclein; cytotoxicity; endocytosis; NMDA; RAB5B; PARKINSONS-DISEASE; GLUTAMATE RECEPTORS; LEWY BODIES; FATTY-ACIDS; DEMENTIA; MUTATION; BRAIN; LOCALIZATION; ACTIVATION; PATHWAYS;
D O I
10.1111/j.1471-4159.2011.07460.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Abnormalities of alpha-synuclein (alpha-syn) and NMDA receptors (NMDARs) are implicated in the pathogenesis of Parkinson's disease. However, how these proteins interact with each other has not been elucidated. Here, the effect of alpha-syn on NMDARs was investigated by examining the alterations of surface NMDAR NR1 subunits in MES23.5 dopaminergic cells transfected with the human alpha-syn gene as well as in cells treated with extracellularly added human alpha-syn. As demonstrated previously that alpha-syn can enter cells in a non-endocytic manner without being degraded by the cellular proteolytic systems, the extracellularly added alpha-syn entered the cytoplasm of MES23.5 cells in a concentration-dependent manner. Both the alpha-syn-transfected cells and alpha-syn-treated cells exhibited increased intracellular alpha-syn levels and reduced surface NR1 without altering the total NR1. The alpha-syn-induced surface NR1 reduction was accompanied by suppression of NMDA-elicited intracellular Ca2+ elevation and reductions of NMDA-induced caspase 3 activation and cell death, which was abolished by hypotonic shock and K+ depletion, a procedure that blocks clathrin-mediated endocytosis, and by suppression of RAB5B expression with anti-RAB5B oligonucleotides. The data obtained provide evidence for the first time that alpha-syn may promote clathrin-mediated NMDAR endocytosis.
引用
收藏
页码:815 / 825
页数:11
相关论文
共 56 条
[1]
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial [J].
Aarsland, Dag ;
Ballard, Clive ;
Walker, Zuzana ;
Bostrom, Fredrik ;
Alves, Guido ;
Kossakowski, Katja ;
Leroi, Iracema ;
Pozo-Rodriguez, Francisco ;
Minthon, Lennart ;
Londos, Elisabet .
LANCET NEUROLOGY, 2009, 8 (07) :613-618
[2]
Amino acid sequence motifs and mechanistic features of the membrane translocation of α-synuclein [J].
Ahn, KJ ;
Paik, SR ;
Chung, KC ;
Kim, J .
JOURNAL OF NEUROCHEMISTRY, 2006, 97 (01) :265-279
[3]
Alim MA, 2004, J ALZHEIMERS DIS, V6, P435
[4]
Antisense oligonucleotide against GTPase Rab5b inhibits metabotropic agonist DHPG-induced neuroprotection [J].
Arnett, ALH ;
Bayazitov, I ;
Blaabjerg, M ;
Fang, LW ;
Zimmer, J ;
Baskys, A .
BRAIN RESEARCH, 2004, 1028 (01) :59-65
[5]
Baba M, 1998, AM J PATHOL, V152, P879
[6]
BANK HL, 1988, IN VITRO CELL DEV B, V24, P266
[7]
Activation of neuroprotective pathways by metabotropic group I glutamate receptors: A potential target for drug discovery? [J].
Baskys, A ;
Fang, LW ;
Bayazitov, I .
NEUROPROTECTIVE AGENTS, 2005, 1053 :55-73
[8]
α-Synuclein and Polyunsaturated Fatty Acids Promote Clathrin-Mediated Endocytosis and Synaptic Vesicle Recycling [J].
Ben Gedalya, Tziona ;
Loeb, Virginie ;
Israeli, Eitan ;
Altschuler, Yoram ;
Selkoe, Dennis J. ;
Sharon, Ronit .
TRAFFIC, 2009, 10 (02) :218-234
[9]
Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents [J].
Blaabjerg, M ;
Fang, LW ;
Zimmer, J ;
Baskys, A .
EXPERIMENTAL NEUROLOGY, 2003, 183 (02) :573-580
[10]
Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS [J].
Boado, RJ ;
Tsukamoto, H ;
Pardridge, WM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) :1308-1315